1. Cheung PK, Lapointe HR, Sang Y, Ennis S, et al.
   SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive ART.
   AIDS 2023.
   


2. Gabert R, Lama JR, Valdez R, Dasgupta S, et al.
   Acute retroviral syndrome is associated with lower CD4 nadir and delayed viral suppression, which are blunted by immediate ART initiation.
   AIDS 2023.
   


3. Casado JL, Vizcarra P, Martin-Colmenarejo S, Del Pino J, et al.
   Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people living with HIV.
   AIDS 2023.
   


4. Chaisson LH, Semitala FC, Nangobi F, Steinmetz S, et al.
   Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3HP.
   AIDS 2023.
   


5. Alfie LG, Longueira YS, Pippo M, Cruces L, et al.
   Increased risk of false positive HIV ELISA results after COVID-19.
   AIDS 2023.
   


6. Slogrove AL, Davies MA, Phelanyane F, De Beer S, et al.
   Hypertensive disorders of pregnancy and HIV: analysis of a province-wide cohort during 2018 and 2019.
   AIDS 2023.
   


7. Svensson Akusjarvi S, Krishnan S, Ambikan AT, Mikaeloff F, et al.
   Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment.
   AIDS 2023.
   


8. Zhu W, Huang YA, Song R, Wiener J, et al.
   An estimate of excess deaths among people with HIV during the COVID-19 pandemic in the United States, 2020.
   AIDS 2023.
   


9. Huang Y, Liao Z, Dang P, Queen S, et al.
   Longitudinal characterization of circulating extracellular vesicles and small RNA during simian immunodeficiency virus infection and antiretroviral therapy.
   AIDS 2023.
   


10. Masters MC, Granche J, Yang J, Overton ET, et al.
    Association between metformin use and cognitive and physical function in persons with HIV and diabetes.
    AIDS Res Hum Retroviruses 2023.
    


11. Hallmark CJ, Luswata C, Del Vecchio N, Hayford C, et al.
    Predictors of HIV Molecular Cluster Membership and Implications for Partner Services.
    AIDS Res Hum Retroviruses 2023.
    


12. Nalintya E, Sekar P, Kavuma P, Kigozi J, et al.
    Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda.
    Clin Infect Dis 2023.
    


13. Heath PT, Galiza EP, Baxter DN, Boffito M, et al.
    Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
    Clin Infect Dis 2022.
    


14. Van Dijck C, Hens N, Kenyon C, Tsoumanis A, et al.
    The roles of unrecognized monkeypox cases, contact isolation and vaccination in determining epidemic size in Belgium. A modelling study.
    Clin Infect Dis 2022.
    


15. Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, et al.
    Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae.
    Clin Infect Dis 2022.
    


16. Moestrup KS, Reekie J, Zucco AG, Jensen TO, et al.
    Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19.
    Clin Infect Dis 2022.
    


17. Montejano R, de la Calle-Prieto F, Velasco M, Guijarro C, et al.
    Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial.
    Clin Infect Dis 2022.
    


18. Mejia-Chew C, Carver PL, Rutjanawech S, Camargo LFA, et al.
    Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study.
    Clin Infect Dis 2023;76:e995-e1003.
    


19. Nash D, Rane MS, Robertson MM, Chang M, et al.
    SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults.
    Clin Infect Dis 2022.
    


20. Wang M, Violette LR, Dorward J, Ngobese H, et al.
    Delivery of Community-based Antiretroviral Therapy to MaintainViral Suppression and Retention in Care in South Africa.
    J Acquir Immune Defic Syndr 2023.
    


21. Van Praet JT, Serrien B, Ausselet N, Darcis G, et al.
    Dynamics of weight change after initiation of contemporaneous antiretroviral therapy in treatment-naive HIV-1 patients: results from the Belgian HIV Cohort 2015-2021.
    J Acquir Immune Defic Syndr 2023.
    


22. Hickey MD, Wafula E, Ogachi SM, Ojwando H, et al.
    Weight change following switch to dolutegravir for HIV treatment in rural Kenya during country roll-out.
    J Acquir Immune Defic Syndr 2023.
    


23. .
    Modeling the Risk of HIV Transfusion Transmission: Erratum.
    J Acquir Immune Defic Syndr 2023;92:271.
    


24. Cohen KW, Fiore-Gartland A, Walsh SR, Yusim K, et al.
    Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults.
    J Clin Invest 2023;133.
    


25. Poveda E, Fitzgerald W, Reglero C, Perez-Gonzalez A, et al.
    IL-18 and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1.
    J Infect Dis 2023.
    


26. Li Y, Peng X, Fu L, Wang B, et al.
    Monkeypox awareness and low vaccination hesitancy among men who have sex with men in China.
    J Med Virol 2023.
    


27. Ohkura S, Horie M, Shimizu M, Nakagawa S, et al.
    Characterization of Megabat-Favored, CA-Dependent Susceptibility to Retrovirus Infection.
    J Virol 2023.
    


28. Bacha JM, Dlamini S, Anabwani F, Gwimile J, et al.
    Realizing the Promise of Dolutegravir in Effectively Treating Children and Adolescents Living With HIV in Real-world Settings in 6 Countries in Eastern and Southern Africa.
    Pediatr Infect Dis J 2023.
    


29. Sutcliffe CG, Moyo N, Hamahuwa M, Mutanga JN, et al.
    The Evolving Pediatric HIV Epidemic in Rural Southern Zambia: The Beneficial Impact of Advances in Prevention and Treatment at a District Hospital From 2007 to 2019.
    Pediatr Infect Dis J 2023.
    


30. Dodi I, Romanini E, Veronese P, Cangelosi AM, et al.
    Highly Active Antiretroviral Therapy in an Extremely Low Birth Weight Newborn With in Utero Transmission of HIV.
    Pediatr Infect Dis J 2023.
    


31. Belsham M, Holbrook A, George JW, Durant HE, et al.
    Corrigendum to "Discovery of candidate HIV-1 latency biomarkers using an OMICs approach" [Virology (2021 Jun) 558 86-95, Epub 2021 Mar 11].
    Virology 2023;580:61.
    


32. Nazareth J, Fahad M, Pareek M.
    Mitigating the return of acute respiratory virus infections.
    BMJ 2023;380:352.
    

Display articles in

• Abstract format
• Medline format